 |
 |
 |
 |
 |
 |
 |
 |
|
|
 |
What's newIMPORTANT NOTICE - ICCBBA has changed their telephone and fax numbers. The new telephone number is +1 909 793-6516. The new fax number is +1 909 793-6214. Please update your contact info to reflect these changes. GS1 and ICCBBA meeting report - read here for a report on GS1 and ICCBBA's international project to advance global standards for bar coding of Plasma Derivative products. 19 November 2008 Technical Specification v3.4.0 - A new version of the ISBT 128 Technical Specification has been released and supersedes the previous 3.3.0 version. Changes made to the new version can be tracked in its internal version control sheet found in Section 1.1. 4 November 2008 Technical Bulletin 9 - A new Technical Bulletin has been published in support of the interface between GS1 and ISBT 128. This document pertains specifically to blood bag identification using GS1 and ISBT 128. 4 November 2008 Version 3.20.0 of the ISBT 128 product code database is now available to licensed facilities. Updates are listed in the version control sheet. The new database can be downloaded as an Access database or as text file tables. Registered facilities database - An updated facility identification database is now available to licensed facilities. The database contains the names and locations of all ICCBBA registered facilities worldwide and their assigned facility identification numbers. It is available both as an Excel file (collection_facilities.xls) and as a tab delimited Text file (collection_facilities.txt). Both documents are available from the download area of the web site. Amendments to entries in these tables should be notified to the ICCBBA office. (For US facilities registered and/or licensed with the FDA, the name and location of your facility should match what appears on your FDA registration or license.) View it here. 3 November 2008 Registration and Licensing Fees 2009 - Each year, the annual license fee is established by the Board of Directors according to a schedule that indexes several factors. Chief among these is funding the annual cost of operations for supporting, maintaining and administering the ongoing development of the standard for the benefit of all licensee organizations. Additional factors in calculating the license fee include the type of licensee organization, and the international location of the organization in accordance with the U.N.'s Human Development Index for developing countries. Despite inflationary pressures, the Board has managed to maintain the same level of fees for the last seven years. For 2009 there will be a 4.9% increase in the per unit charge for Facilities (from US$0.01125 per unit to US$0.0118 per unit), and an increase in the minimum fee to $150. Facilities in Medium and Low HDI countries will continue to receive a reduction on these rates. Vendor license fees will be unchanged. ICCBBA is a not-for-profit organization committed to improving patient safety through standardization and all income is used towards maintaining and developing the ISBT 128 Standard and achieving the aim of global standardization. 30 October 2008 US Consensus Standard DRAFT - The United States Industry Consensus Standard for the Uniform Labeling of Blood and Blood Components using ISBT 128, Version 3, DRAFT C is now available for public comment until December 1st. All comments will be taken into consideration prior to the final publication of the document. Please your comments to ICCBBA. 24 September 2008 Product Code Structure and Labeling Documents - all three documents have a new updated version for blood, cellular therapy, and tissues. They are available in the registered users' area of the website and will require users to log in to view them. 24 September 2008 US Cellular Therapy Document - The United States Industry Consensus Standard for the Uniform Labeling of Cellular Therapy Products using ISBT 128, Version 1, DRAFT I is the result of the collaborative efforts of AABB, ASBMT, ASFA, FACT, ICCBBA, ISCT, and NMDP. It is available for public comment until August 1, 2008. All comments will be taken into consideration prior to the final publication of the document. Please your comments to ICCBBA. 19 May 2008 Annual Award - ICCBBA announces the inauguration of an annual award. This award will recognize professionals whose cumulative record demonstrates an important contribution to the understanding and application of international information standards in transfusion and transplantation medicine. Click here for more information. 13 May 2007 Technical Specification v3.3.0 - A new version of the ISBT 128 Technical Specification has been released and supersedes the previous 3.2.0 version. Changes made to the new version can be tracked in its version control sheet. 12 May 2008 Document name change - The document formerly titled Bounded Lists and Definitions was recently changed to Standard Terminology for Blood, Cellular Therapy, and Tissue Product Descriptions. Aside from the usual monthly updates, the contents and structure of the document remains consistent. Please view its version control sheet to track the monthly updates. 5 May 2008 GS1 and ICCBBA Collaboration - Read here for an update on what GS1 and ICCBBA are doing to standardize labeling for blood derivatives that can be read by either GS1 or ISBT 128 compatible software. 19 March 2008 Special Testing database - a new version of the Special Testing database has been posted to reflect retired codes. 4 March 2008
|
